(Q55026990)

15 June 2018

title

Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer. (English)

1 reference

15 June 2018

author name string

Jacques Raphael

1

1 reference

15 June 2018

I Y Gong

2

1 reference

15 June 2018

S Nofech-Mozes

3

1 reference

15 June 2018

Jms Bartlett

4

1 reference

15 June 2018

H Nafisi

5

1 reference

15 June 2018

S Verma

6

1 reference

15 June 2018

language of work or name

English

0 references

publication date

7 March 2016

1 reference

15 June 2018

Journal of Clinical Pathology

published in

1 reference

15 June 2018

volume

69

1 reference

15 June 2018

issue

6

1 reference

15 June 2018

page(s)

552-555

1 reference

15 June 2018

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203493

Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203493

Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203493

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203493

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203493

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203493

The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203493

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203493

Tumour-infiltrating macrophages and clinical outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2015-203493

10.1136/JCLINPATH-2015-203493

21 January 2018

Identifiers

DOI

1 reference

15 June 2018

1 reference

15 June 2018